MARKET

PBH

PBH

Prestige Consmr Healthcare Inc
NYSE

Real-time Quotes | Nasdaq Last Sale

53.26
-2.03
-3.67%
After Hours: 53.26 0 0.00% 16:19 05/19 EDT
OPEN
55.04
PREV CLOSE
55.29
HIGH
55.45
LOW
53.19
VOLUME
316.19K
TURNOVER
0
52 WEEK HIGH
63.83
52 WEEK LOW
48.77
MARKET CAP
2.68B
P/E (TTM)
13.18
1D
5D
1M
3M
1Y
5Y
--Jefferies Upgrades Prestige Consumer Healthcare to Buy From Hold, Adjusts Price Target to $70 From $65
MT Newswires · 05/10 05:57
27 Recession-Resistant Stocks To Look At Now
When we enter a period of economic uncertainty, the phrase "recession-proof stocks" is tossed about, but really the only certainty is that recession-proof stocks do not exist. On the other hand, recession-resistant companies are what a savvy investor searc...
Benzinga · 05/09 17:26
Prestige Consumer Healthcare is top small-cap pick at Oppenheimer
A strong earnings result and a still attractive price to earnings ratio for Prestige Consumer Healthcare (NYSE:PBH) is prompting a more bullish view from Oppenheimer analyst Rupesh Parikh. The New
Seekingalpha · 05/09 14:10
Benzinga's Top Ratings Upgrades, Downgrades For May 9, 2022
Upgrades
Benzinga · 05/09 14:07
--DA Davidson Lowers Prestige Consumer Healthcare's Price Target to $60 From $63, Maintains Neutral Rating
MT Newswires · 05/09 11:36
--Oppenheimer Upgrades Prestige Consumer Healthcare to Outperform From Perform, Sets $63 Price Target
MT Newswires · 05/09 09:20
Prestige reports 5.9% organic revenue growth, initiates guidance above estimate
Prestige (NYSE:PBH) has reported easy beat on both lines in its fourth quarter earnings results with next year's guidance placed above the consensus mark. Revenue of $266.94M (+12.3% Y/Y) beats by
Seekingalpha · 05/06 13:16
Prestige Brands (PBH) Tops Q4 Earnings and Revenue Estimates
Prestige Brands (PBH) delivered earnings and revenue surprises of 2.25% and 3.38%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 05/06 00:25
More
No Data
Learn about the latest financial forecast of PBH. Analyze the recent business situations of Prestige Consmr Healthcare Inc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 7 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

57.14%Strong Buy
28.57%Buy
14.29%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average PBH stock price target is 66.40 with a high estimate of 72.00 and a low estimate of 60.00.
High72.00
Average66.40
Low60.00
Current 53.26
EPS
Actual
Estimate
0.280.570.851.14
Q1 2022
Q2 2022
Q3 2022
Q4 2022
Q1 2023
Institutional Holdings
Institutions: 393
Institutional Holdings: 60.34M
% Owned: 120.02%
Shares Outstanding: 50.28M
TypeInstitutionsShares
Increased
92
1.33M
New
42
1.68M
Decreased
99
3.08M
Sold Out
17
152.75K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
+0.15%
Pharmaceuticals & Medical Research
+0.51%
Key Executives
Chairman/President/Chief Executive Officer/Director
Ronald Lombardi
Chief Financial Officer
Christine Sacco
Executive Vice President/Director of Sales/Director of Marketing
Adel Mekhail
Senior Vice President/General Counsel/Secretary
William PPool
Senior Vice President
Jeffrey Zerillo
Independent Director
John Byom
Independent Director
Celeste Clark
Independent Director
Christopher Coughlin
Independent Director
Sheila Hopkins
Independent Director
Natale Ricciardi
Independent Director
Dawn Zier
No Data
No Data
About PBH
Prestige Consumer Healthcare Inc. is engaged in the marketing, sales and distribution of over the counter (OTC) healthcare products to mass merchandisers, drug, food, dollar, convenience and club stores and e-commerce channels in North America (the United States and Canada), and in Australia and certain other international markets. The Company operates through two segments: North American OTC Healthcare and International OTC Healthcare. Its brands include BC/Goody's, Boudreaux's Butt Paste, Chloraseptic, Clear Eyes, Compound W, Debrox, DenTek, Dramamine, Fleet, Gaviscon, Luden's, Monistat, Nix, Summer's Eve, Fess and Hydralyte. Its subsidiaries include Blacksmith Brands, Inc., C.B. Fleet TopCo, LLC, C.B. Fleet HoldCo, LLC, C.B. Fleet, LLC, C.B. Fleet Company, Incorporated and C.B. Fleet Investment Corporation.

Webull offers kinds of Prestige Consumer Healthcare Inc stock information, including NYSE:PBH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PBH stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading PBH stock methods without spending real money on the virtual paper trading platform.